SER · trading date Oct 13, 2026 · previous close $1.91 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$130.0K
Net income
-$19.18M
Total assets
$6.95M
Total liabilities
$6.99M
Stockholders' equity
-$37.0K
Cash & equivalents
$3.06M
Operating income
-$24.02M
Operating cash flow
-$17.96M
Capital expenditures
$59.0K
Fiscal year 2025, via 10-K filed 2026-03-25.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-18,478.5%
Net margin
-14,755.4%
Free cash flow
-$18.01M
Free cash flow margin
-13,856.9%
Liabilities / assets
100.5%
Equity / assets
-0.5%
CapEx / revenue
45.4%
Operating cash flow / net income
0.94×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Huntsville, AL 35806
601 GENOME WAY
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:12 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.